Advances in Immunotherapy for Malignant Pleural Mesothelioma: From Emerging Strategies to Translational Insights
MPM stands as a rare malignancy necessitating improved therapeutic strategies due to its limited treatment choices and unfavorable prognosis. The advent of immune checkpoint inhibitors has heralded a paradigm shift in the therapeutic landscape of […]